Stock Events

Stock Events

Oasmia Pharmaceutical AB 

$0
0
+$0+0% Wednesday 13:30

Statistics

Day High
0
Day Low
0
52W High
0.2
52W Low
0
Volume
-
Avg. Volume
-
Mkt Cap
53,804.3
P/E Ratio
-
Dividend Yield
840%
Dividend
0

Upcoming

28
JAN 27
Dividend Ex
Estimated
 
4
FEB 27
Dividend Payment
Estimated
 
28
JAN 28
Dividend Ex
Estimated
 
4
FEB 28
Dividend Payment
Estimated
 

Dividends

840%Dividend Yield
Feb 26
$0
Apr 22
$0
Dec 19
$0.23
Jul 17
$0.02
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

21NovExpected
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q1 2024
Q2 2024
Q3 2024
-0.04
-0.03
-0.01
0
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-12.62MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow OASMY. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap102.71B
Medtronic plc is a major player in the medical technology, services, and solutions sector, directly competing with Vivesto AB in the medical devices market.
Boston Scientific
BSX
Mkt Cap83.97B
Boston Scientific Corporation specializes in the development of medical devices that are used in various interventional medical specialties, competing with Vivesto AB's offerings.
Stryker
SYK
Mkt Cap112.88B
Stryker Corporation is a leader in the medical technology industry and competes with Vivesto AB in the orthopedics and surgical sectors.
Abbott Laboratories
ABT
Mkt Cap155.82B
Abbott Laboratories operates globally in more than 160 countries, offering a broad range of healthcare products that compete with Vivesto AB's medical devices.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson is a comprehensive healthcare firm that manufactures medical devices, pharmaceuticals, and consumer health products, competing across multiple fronts with Vivesto AB.
Zimmer Biomet
ZBH
Mkt Cap16.05B
Zimmer Biomet Holdings, Inc. specializes in musculoskeletal healthcare and competes with Vivesto AB in the orthopedic device sector.
Intuitive Surgical
ISRG
Mkt Cap162.13B
Intuitive Surgical, Inc. offers robotic-assisted surgical systems, directly competing with Vivesto AB's technological innovations in surgery.
Edwards Lifesciences
EW
Mkt Cap48.42B
Edwards Lifesciences Corporation is focused on advanced medical equipment for structural heart disease and critical care monitoring, competing with Vivesto AB's similar medical device solutions.
Baxter International
BAX
Mkt Cap8.88B
Baxter International Inc. provides a portfolio of healthcare products, including hospital and renal care products, competing with Vivesto AB in the medical supplies sector.

About

Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology primarily in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.
Show more...
CEO
Mr. Erik Kinnman Assoc. Prof., M.B.A., M.D., Ph.D.
Employees
4
Country
Sweden
ISIN
US67421W1099

Listings

STU
DE
OMAX.STU
LSE
GB
0N4A.LSE
ST
SE
VIVE.ST
OTCM
US
OASMY

0 Comments

Share your thoughts

FAQ

What is Oasmia Pharmaceutical AB stock price today?▼
The current price of OASMY is $0 USD — it has increased by +0% in the past 24 hours. Watch Oasmia Pharmaceutical AB stock price performance more closely on the chart.
What is Oasmia Pharmaceutical AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Oasmia Pharmaceutical AB stocks are traded under the ticker OASMY.
Is Oasmia Pharmaceutical AB stock price growing?▼
OASMY stock has risen by +0% compared to the previous week, the month change is a -0% fall, over the last year Oasmia Pharmaceutical AB has showed a -99.5% decrease.
What is Oasmia Pharmaceutical AB market cap?▼
Today Oasmia Pharmaceutical AB has the market capitalization of 53,804.3
What is Oasmia Pharmaceutical AB revenue for the last year?▼
Oasmia Pharmaceutical AB revenue for the last year amounts to 0 USD.
What is Oasmia Pharmaceutical AB net income for the last year?▼
OASMY net income for the last year is -12.62M USD.
Does Oasmia Pharmaceutical AB pay dividends?▼
Yes, OASMY dividends are paid en. The last dividend per share was 0 USD. As of today, Dividend Yield (FWD)% is 840%.
How many employees does Oasmia Pharmaceutical AB have?▼
As of May 06, 2026, the company has 4 employees.
In which sector is Oasmia Pharmaceutical AB located?▼
Oasmia Pharmaceutical AB operates in the Health & Wellness sector.
When did Oasmia Pharmaceutical AB complete a stock split?▼
Oasmia Pharmaceutical AB has not had any recent stock splits.
Where is Oasmia Pharmaceutical AB headquartered?▼
Oasmia Pharmaceutical AB is headquartered in Solna, Sweden.